Solara Active Pharma Sciences ESG Rating Upgraded to Crisil ESG 63
Solara Active Pharma Sciences Ltd 路 Others (Uncategorized) 路 10 Oct 2026, 11:55 pm
Solara Active Pharma Sciences ESG Rating Upgraded to Crisil ESG 63 Solara Active Pharma Sciences Limited received an upgraded Environmental, Social, and Governance (ESG) rating of 'Crisil ESG 63' under the 'Strong' category for FY26 (period ended 31st Mar'26) from Crisil ESG Ratings & Analytics Limited, up from 'Crisil ESG 56' for FY25. The rating was assigned independently without company engagement, evaluated on public disclosures and financial year information.
Original exchange filing (PDF)
More announcements from Solara Active Pharma Sciences Ltd
- Transcript of Earnings Conference call pertaining to financial results of the Company for the quarter ended September 30, 2026 路 23 Oct 2026
- Solara Active Pharma Sciences Limited has informed the Exchange regarding the dispatch of Final Reminder -cum-Forfeiture Notice for the payment of outstanding call money to the holders .... 路 18 Oct 2026
- Monitoring Agency Report for the quarter ended September 30, 2026 路 17 Oct 2026
- Audio recordings of Q2 FY27 earnings call conducted on October 16, 2026, for the quarter ended September 30, 2026 路 17 Oct 2026
- Solara Active Pharma Sciences Limited has informed the exchange about the Statement of Deviation/Variation in utilization of funds raised though Rights issue for the quarter ended September 30 2026 路 16 Oct 2026
- Solara Active Pharma Sciences Limited has informed the Exchange regarding grant of 470000 options under Solara Employee Stock Option Plan 2024 路 16 Oct 2026
- Solara Active Pharma Sciences Limited has informed the Exchange regarding a Press Release dated October 16, 2026, titled "Solara''s Q2 FY 27 revenue grows 33% to INR 4,178 Mn and EBITDA .... 路 16 Oct 2026
- Solara Active Pharma Sciences Limited has informed the Exchange regarding allotment of 8,300 Equity shares pursuant to exercise of ESOP options. 路 16 Oct 2026
